For Cury et al., although any medication use was associated with nephrolithiasis, it did not reach statistical significance when controlled for the activity of the disease [ 1 ].
← all excerpts
Risk of Nephrolithiasis in Patients with Inflammatory Bowel Disease Receiving Biologic Treatment.
1
—
—